Pangenomic Health Inc. NARA
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -482.60K | -665.70K | -624.90K | -1.28M | -286.90K |
| Total Depreciation and Amortization | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 361.80K | 480.60K | 342.30K | 452.20K | 1.80K |
| Change in Net Operating Assets | -66.30K | -7.60K | 130.20K | -237.40K | 169.80K |
| Cash from Operations | -187.00K | -192.70K | -152.30K | -1.06M | -115.20K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 232.50K | 270.00K | -7.50K | 0.00 | 143.20K |
| Total Debt Repaid | -- | -- | 176.40K | -125.00K | -62.50K |
| Issuance of Common Stock | -- | -- | 5.90K | 1.66M | 88.60K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -5.90K | 6.00K | -6.00K |
| Cash from Financing | 163.70K | 194.20K | 121.10K | 1.12M | 118.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -23.30K | 1.50K | -31.10K | 55.00K | 2.80K |